Elig.phs000096.v4.p1.1
Item
A pregnant woman was *ineligible* to participate in HAPO if any of the following exclusion criteria applied:
boolean
C0680251 (UMLS CUI [1,1])
Elig.phs000096.v4.p1.2
Item
Age < 18 years, i.e., has not completed 18th year of life by the first interview.
boolean
C1298908 (UMLS CUI [1,1])
C0001675 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
C0021822 (UMLS CUI [1,5])
Elig.phs000096.v4.p1.3
Item
Planning to deliver at another hospital or location.
boolean
C1301732 (UMLS CUI [1,1])
C1384485 (UMLS CUI [1,2])
C1547118 (UMLS CUI [1,3])
Elig.phs000096.v4.p1.4
Item
Date of last menstrual period is not certain AND no ultrasound estimation from 6-24 weeks of gestational age is available or will be available.
boolean
C0425932 (UMLS CUI [1,1])
C0087130 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
C0041618 (UMLS CUI [1,5])
C4323880 (UMLS CUI [1,6])
C0730522 (UMLS CUI [1,7])
Elig.phs000096.v4.p1.5
Item
Unable to complete OGTT within 32 weeks gestation, or currently > 31 weeks gestation.
boolean
C1299582 (UMLS CUI [1,1])
C0029161 (UMLS CUI [1,2])
C0233039 (UMLS CUI [1,3])
Elig.phs000096.v4.p1.6
Item
Known multiple pregnancy.
boolean
C0032989 (UMLS CUI [1,1])
Elig.phs000096.v4.p1.7
Item
Became pregnant with assistance of advanced reproductive technology such as in vitro fertilization (IVF) or superovulation with gonadotropins.
boolean
C0032961 (UMLS CUI [1,1])
C0015915 (UMLS CUI [1,2])
C0842347 (UMLS CUI [1,3])
Elig.phs000096.v4.p1.8
Item
Any unblinded blood glucose testing AND/OR diagnosis of GDM during this pregnancy prior to enrollment in this protocol.
boolean
C4553913 (UMLS CUI [1,1])
C0392201 (UMLS CUI [1,2])
C0011900 (UMLS CUI [2,1])
C0085207 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C1516879 (UMLS CUI [2,4])
Elig.phs000096.v4.p1.9
Item
Previous diagnosis of diabetes requiring treatment with medication outside of pregnancy.
boolean
C0011900 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
C3274787 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C0032961 (UMLS CUI [1,5])
Elig.phs000096.v4.p1.10
Item
Currently receiving treatment with oral glucocorticoids, thiazide diuretics, -blockers, ACE inhibitors, oral -mimetics, dilantin, or antiretroviral agents.
boolean
C5223764 (UMLS CUI [1,1])
C0017710 (UMLS CUI [1,2])
C0012802 (UMLS CUI [1,3])
C0003015 (UMLS CUI [1,4])
C0699512 (UMLS CUI [1,5])
C0599685 (UMLS CUI [1,6])
C0001645 (UMLS CUI [1,7])
C3846158 (UMLS CUI [1,8])
Elig.phs000096.v4.p1.11
Item
Participation in another study which may interfere with the HAPO Study.
boolean
C2348568 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2603343 (UMLS CUI [1,3])
Elig.phs000096.v4.p1.12
Item
Known to be HIV positive or to have Hepatitis B or C.
boolean
C0019693 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
Elig.phs000096.v4.p1.13
Item
Participation in the HAPO Study during a previous pregnancy.
boolean
C2348568 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0032961 (UMLS CUI [1,4])
Elig.phs000096.v4.p1.14
Item
Inability to converse in language(s) used in field center forms without the aid of an interpreter.
boolean
C4062227 (UMLS CUI [1,1])
Elig.phs000096.v4.p1.15
Item
*Note:* Women with any of the exclusion criteria present (except 11) were excluded since any of these criteria may confound study results. Women with criterion 11 present were excluded for protection of others since blood samples were transported across international borders.
boolean
C0680251 (UMLS CUI [1,1])